B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20118770

Download in:

View as

General Info

PMID
20118770